2015


Basel-Stadt

Homepage

Company profile

T3 Pharmaceuticals AG

The team at T3 Pharmaceuticals is taking an unusual approach in the fight against malignant tumours. The method involves infecting the tumours with live bacteria. A financing round in November 2016 gave the startup the funds it needs to grow and conduct preclinical trials.


Source: startup.ch

Highlights

More news about T3 Pharmaceuticals AG

12.11.2018 15:44

T3 Pharma wins the title “2018 Science Start-Up of the Year”

Award
Please login or
register to use the
bookmark feature
18.09.2017 11:22

BaseLaunch startups: From gene therapies to digital measurement

Support
Please login or
register to use the
bookmark feature
19.04.2017 09:20

15 Swiss startups to present at Swiss Biotech Day

BackgroundSupport
Please login or
register to use the
bookmark feature
28.11.2016 13:30

T3 Pharma closes first financing round

Financing
Please login or
register to use the
bookmark feature
02.11.2016 17:00

Tech startups awarded the CTI Label

Award
Please login or
register to use the
bookmark feature
01.07.2016 10:40

>>venture>> 2016: Krebsmedikamente und neue Materialien vorn

Award
Please login or
register to use the
bookmark feature

Principal

A showcase for female CEOs


Startupticker has recorded Swiss start-ups with female CEOs and ranked them by sector. The map which includes links to 80+ companies can be downloaded in our article.

Partners

Contributors

By continuing to use this website you agree with our TERMS AND CONDITIONS